ALKSAlkermes plc.
- Market cap
- $7.32B
- as of 2026-10-23
- Latest close
- $43.63
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Drug Manufacturers - Specialty & Generic
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2023-12-12
Dashed line = amended filing (Form 4/A)
Showing the latest 500 of 740 transactions.
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Reed JoshuaSVP, Chief Financial Officer | Oct 8 | Oct 9 | M | 9,164 | not reported | not reported | 9,164 | No | Form 4 |
| Reed JoshuaSVP, Chief Financial Officer | Oct 8 | Oct 9 | F | 4,069 | $40.11 | $163,208 | 5,095 | No | Form 4 |
| Reed JoshuaSVP, Chief Financial Officer | Oct 8 | Oct 9 | M · derivative | 9,164 | not reported | not reported | 27,492 | No | Form 4 |
| Whitaker Anne Clem | Oct 7 | Oct 9 | A · derivative | 7,239 | $0.00 | $0 | 7,239 | No | Form 4 |
| Whitaker Anne Clem | Oct 7 | Oct 9 | A · derivative | 17,998 | $41.45 | $745,927 | 17,998 | No | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Oct 2 | Oct 2 | S | 2,034 | $41.03 | Sale −$83,455 | 221,388 | Yes | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Sep 3 | Sep 3 | S | 2,034 | $48.01 | Sale −$97,652 | 223,422 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Sep 1 | Sep 1 | M | 5,000 | $24.59 | $122,950 | 74,389 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Sep 1 | Sep 1 | S | 9,000 | $46.99 | Sale −$422,910 | 65,389 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Sep 1 | Sep 1 | M · derivative | 5,000 | $24.59 | $122,950 | 61,276 | Yes | Form 4 |
| Nichols Christian ToddSVP, Chief Commercial Officer | Aug 17 | Aug 17 | S | 6,912 | $49.19 | Sale −$340,001 | 102,857 | Yes | Form 4 |
| Nichols Christian ToddSVP, Chief Commercial Officer | Aug 17 | Aug 17 | S | 664 | $49.65 | Sale −$32,968 | 102,193 | Yes | Form 4 |
| Jackson Blair CurtisPresident & CEO, Alkermes plc | Aug 5 | Aug 7 | A · derivative | 93,229 | $49.61 | $4,625,091 | 93,229 | No | Form 4 |
| Jackson Blair CurtisPresident & CEO, Alkermes plc | Aug 5 | Aug 7 | A · derivative | 124,305 | $49.61 | $6,166,771 | 124,305 | No | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Aug 3 | Aug 3 | S | 2,034 | $48.58 | Sale −$98,812 | 225,456 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Aug 3 | Aug 3 | M | 104 | $19.34 | $2,011 | 73,493 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Aug 3 | Aug 3 | M | 4,896 | $24.59 | $120,393 | 78,389 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Aug 3 | Aug 3 | S | 9,000 | $48.58 | Sale −$437,220 | 69,389 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Aug 3 | Aug 3 | M · derivative | 104 | $19.34 | $2,011 | 1,252 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Aug 3 | Aug 3 | M · derivative | 4,896 | $24.59 | $120,393 | 66,276 | Yes | Form 4 |
| snyderman nancy lynn MD | Aug 3 | Aug 3 | M | 27,948 | $46.72 | $1,305,731 | 43,343 | No | Form 4 |
| snyderman nancy lynn MD | Aug 3 | Aug 3 | M | 16,524 | $46.72 | $772,001 | 59,867 | No | Form 4 |
| snyderman nancy lynn MD | Aug 3 | Aug 3 | S | 44,472 | $50.35 | Sale −$2,239,165 | 15,395 | No | Form 4 |
| snyderman nancy lynn MD | Aug 3 | Aug 3 | M · derivative | 27,948 | $46.72 | $1,305,731 | not reported | No | Form 4 |
| snyderman nancy lynn MD | Aug 3 | Aug 3 | M · derivative | 16,524 | $46.72 | $772,001 | not reported | No | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Jul 6 | Jul 6 | S | 2,034 | $54.03 | Sale −$109,897 | 227,490 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Jul 1 | Jul 1 | M | 5,000 | $19.34 | $96,700 | 82,389 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Jul 1 | Jul 1 | S | 8,300 | $51.46 | Sale −$427,118 | 74,089 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Jul 1 | Jul 1 | S | 700 | $52.13 | Sale −$36,491 | 73,389 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Jul 1 | Jul 1 | M · derivative | 5,000 | $19.34 | $96,700 | 1,356 | Yes | Form 4 |
| Wright Christopher I | Jun 12 | Jun 12 | S | 2,000 | $45.10 | Sale −$90,200 | 25,680 | Yes | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Jun 4 | Jun 4 | S | 2,034 | $43.05 | Sale −$87,564 | 229,524 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Jun 1 | Jun 1 | M | 5,000 | $19.34 | $96,700 | 86,389 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Jun 1 | Jun 1 | S | 9,000 | $41.67 | Sale −$375,030 | 77,389 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Jun 1 | Jun 1 | M · derivative | 5,000 | $19.34 | $96,700 | 6,356 | Yes | Form 4 |
| Parisi Samuel JosephVP, Finance (Interim PAO) | May 29 | May 29 | M | 3,392 | $20.03 | $67,942 | 11,109 | No | Form 4 |
| Parisi Samuel JosephVP, Finance (Interim PAO) | May 29 | May 29 | M | 12,825 | $19.34 | $248,036 | 23,934 | No | Form 4 |
| Parisi Samuel JosephVP, Finance (Interim PAO) | May 29 | May 29 | S | 16,217 | $42.36 | Sale −$686,952 | 7,717 | No | Form 4 |
| Parisi Samuel JosephVP, Finance (Interim PAO) | May 29 | May 29 | M · derivative | 3,392 | $20.03 | $67,942 | 3,394 | No | Form 4 |
| Parisi Samuel JosephVP, Finance (Interim PAO) | May 29 | May 29 | M · derivative | 12,825 | $19.34 | $248,036 | 12,826 | No | Form 4 |
| Laurencin Cato T | May 21 | May 22 | M | 6,142 | not reported | not reported | 35,244 | No | Form 4 |
| Laurencin Cato T | May 21 | May 22 | F | 1,475 | $36.95 | $54,501 | 33,769 | No | Form 4 |
| Laurencin Cato T | May 21 | May 22 | M · derivative | 6,142 | not reported | not reported | not reported | No | Form 4 |
| Lurker Nancy | May 21 | May 22 | M | 6,142 | not reported | not reported | 19,697 | No | Form 4 |
| Lurker Nancy | May 21 | May 22 | F | 1,475 | $36.95 | $54,501 | 18,222 | No | Form 4 |
| Lurker Nancy | May 21 | May 22 | M · derivative | 6,142 | not reported | not reported | not reported | No | Form 4 |
| Mckeon Brian P | May 21 | May 22 | M | 6,142 | not reported | not reported | 40,011 | No | Form 4 |
| Mckeon Brian P | May 21 | May 22 | F | 1,475 | $36.95 | $54,501 | 38,536 | No | Form 4 |
| Mckeon Brian P | May 21 | May 22 | M · derivative | 6,142 | not reported | not reported | not reported | No | Form 4 |
| snyderman nancy lynn MD | May 21 | May 22 | M | 6,142 | not reported | not reported | 16,870 | No | Form 4 |
| snyderman nancy lynn MD | May 21 | May 22 | F | 1,475 | $36.95 | $54,501 | 15,395 | No | Form 4 |
| snyderman nancy lynn MD | May 21 | May 22 | M · derivative | 6,142 | not reported | not reported | not reported | No | Form 4 |
| Wilson Frank Anders | May 21 | May 22 | M | 6,142 | not reported | not reported | 37,226 | No | Form 4 |
| Wilson Frank Anders | May 21 | May 22 | F | 1,475 | $36.95 | $54,501 | 35,751 | No | Form 4 |
| Wilson Frank Anders | May 21 | May 22 | M · derivative | 6,142 | not reported | not reported | not reported | No | Form 4 |
| Wright Christopher I | May 21 | May 22 | M | 6,142 | not reported | not reported | 29,155 | No | Form 4 |
| Wright Christopher I | May 21 | May 22 | F | 1,475 | $36.95 | $54,501 | 27,680 | No | Form 4 |
| Wright Christopher I | May 21 | May 22 | M · derivative | 6,142 | not reported | not reported | not reported | No | Form 4 |
| Cooke Shane | May 20 | May 224/A | A · derivative | 11,538 | $36.98 | $426,675 | 11,538 | No | Form 4/A |
| Cooke Shane | May 20 | May 224/A | A · derivative | 5,409 | $0.00 | $0 | 5,409 | No | Form 4/A |
| Gaynor Richard | May 20 | May 224/A | A · derivative | 11,538 | $36.98 | $426,675 | 11,538 | No | Form 4/A |
| Gaynor Richard | May 20 | May 224/A | A · derivative | 5,409 | $0.00 | $0 | 5,409 | No | Form 4/A |
| Laurencin Cato T | May 20 | May 22 | A · derivative | 11,538 | $36.98 | $426,675 | 11,538 | No | Form 4 |
| Laurencin Cato T | May 20 | May 22 | A · derivative | 5,409 | $0.00 | $0 | 5,409 | No | Form 4 |
| Lurker Nancy | May 20 | May 22 | A · derivative | 11,538 | $36.98 | $426,675 | 11,538 | No | Form 4 |
| Lurker Nancy | May 20 | May 22 | A · derivative | 5,409 | $0.00 | $0 | 5,409 | No | Form 4 |
| Mckeon Brian P | May 20 | May 22 | A · derivative | 11,538 | $36.98 | $426,675 | 11,538 | No | Form 4 |
| Mckeon Brian P | May 20 | May 22 | A · derivative | 5,409 | $0.00 | $0 | 5,409 | No | Form 4 |
| snyderman nancy lynn MD | May 20 | May 22 | A · derivative | 11,538 | $36.98 | $426,675 | 11,538 | No | Form 4 |
| snyderman nancy lynn MD | May 20 | May 22 | A · derivative | 5,409 | $0.00 | $0 | 5,409 | No | Form 4 |
| Wilson Frank Anders | May 20 | May 22 | A · derivative | 11,538 | $36.98 | $426,675 | 11,538 | No | Form 4 |
| Wilson Frank Anders | May 20 | May 22 | A · derivative | 5,409 | $0.00 | $0 | 5,409 | No | Form 4 |
| Wright Christopher I | May 20 | May 22 | A · derivative | 11,538 | $36.98 | $426,675 | 11,538 | No | Form 4 |
| Wright Christopher I | May 20 | May 22 | A · derivative | 5,409 | $0.00 | $0 | 5,409 | No | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | May 4 | May 4 | S | 2,034 | $33.20 | Sale −$67,529 | 231,558 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | May 1 | May 1 | M | 5,000 | $19.34 | $96,700 | 90,389 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | May 1 | May 1 | S | 9,000 | $33.40 | Sale −$300,600 | 81,389 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | May 1 | May 1 | M · derivative | 5,000 | $19.34 | $96,700 | 11,356 | Yes | Form 4 |
| Lurker Nancy | Apr 11 | Apr 13 | M | 3,751 | not reported | not reported | 14,456 | No | Form 4 |
| Lurker Nancy | Apr 11 | Apr 13 | F | 901 | $33.36 | $30,057 | 13,555 | No | Form 4 |
| Lurker Nancy | Apr 11 | Apr 13 | M · derivative | 3,751 | not reported | not reported | 3,752 | No | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Apr 6 | Apr 6 | S | 2,034 | $34.57 | Sale −$70,315 | 233,592 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Apr 1 | Apr 1 | M | 5,000 | $19.34 | $96,700 | 94,389 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Apr 1 | Apr 1 | S | 9,000 | $35.51 | Sale −$319,590 | 85,389 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Apr 1 | Apr 1 | M · derivative | 5,000 | $19.34 | $96,700 | 16,356 | Yes | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Mar 3 | Mar 4 | S | 2,034 | $29.76 | Sale −$60,532 | 235,626 | Yes | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Mar 2 | Mar 4 | S | 2,034 | $29.29 | Sale −$59,576 | 237,660 | Yes | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Mar 2 | Mar 4 | A · derivative | 78,292 | $30.25 | $2,368,333 | 78,292 | Yes | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Mar 2 | Mar 4 | A · derivative | 36,364 | $0.00 | $0 | 36,364 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Mar 2 | Mar 4 | M | 5,000 | $19.34 | $96,700 | 98,389 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Mar 2 | Mar 4 | S | 9,000 | $29.72 | Sale −$267,480 | 89,389 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Mar 2 | Mar 4 | M · derivative | 5,000 | $19.34 | $96,700 | 21,356 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Mar 2 | Mar 4 | A · derivative | 83,037 | $30.25 | $2,511,869 | 83,037 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Mar 2 | Mar 4 | A · derivative | 38,568 | $0.00 | $0 | 38,568 | Yes | Form 4 |
| Jackson Blair CurtisEVP, Chief Operating Officer | Mar 2 | Mar 4 | A · derivative | 94,900 | $30.25 | $2,870,725 | 94,900 | No | Form 4 |
| Jackson Blair CurtisEVP, Chief Operating Officer | Mar 2 | Mar 4 | A · derivative | 44,078 | $0.00 | $0 | 44,078 | No | Form 4 |
| Nichols Christian ToddSVP, Chief Commercial Officer | Mar 2 | Mar 4 | S | 6,000 | $30.00 | Sale −$180,000 | 109,769 | Yes | Form 4 |
| Nichols Christian ToddSVP, Chief Commercial Officer | Mar 2 | Mar 4 | A · derivative | 66,430 | $30.25 | $2,009,508 | 66,430 | Yes | Form 4 |
| Nichols Christian ToddSVP, Chief Commercial Officer | Mar 2 | Mar 4 | A · derivative | 30,854 | $0.00 | $0 | 30,854 | Yes | Form 4 |
| Parisi Samuel JosephVP, Finance (Interim PAO) | Mar 2 | Mar 4 | S | 6,890 | $29.29 | Sale −$201,808 | 7,717 | Yes | Form 4 |
| Parisi Samuel JosephVP, Finance (Interim PAO) | Mar 2 | Mar 4 | A · derivative | 15,033 | $30.25 | $454,748 | 15,033 | Yes | Form 4 |
| Parisi Samuel JosephVP, Finance (Interim PAO) | Mar 2 | Mar 4 | A · derivative | 14,176 | $0.00 | $0 | 14,176 | Yes | Form 4 |
| Pops Richard FDirector and CEO, Alkermes plc | Mar 2 | Mar 4 | A · derivative | 88,843 | $0.00 | $0 | 88,843 | No | Form 4 |
| Reed JoshuaSVP, Chief Financial Officer | Mar 2 | Mar 4 | A · derivative | 66,430 | $30.25 | $2,009,508 | 66,430 | No | Form 4 |
| Reed JoshuaSVP, Chief Financial Officer | Mar 2 | Mar 4 | A · derivative | 30,854 | $0.00 | $0 | 30,854 | No | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Feb 26 | Feb 27 | M | 6,866 | not reported | not reported | 242,743 | No | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Feb 26 | Feb 27 | F | 3,049 | $30.73 | $93,696 | 239,694 | No | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Feb 26 | Feb 27 | M · derivative | 6,866 | not reported | not reported | 13,732 | No | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 26 | Feb 27 | M | 6,866 | not reported | not reported | 96,438 | No | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 26 | Feb 27 | F | 3,049 | $30.73 | $93,696 | 93,389 | No | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 26 | Feb 27 | M · derivative | 6,866 | not reported | not reported | 13,732 | No | Form 4 |
| Jackson Blair CurtisEVP, Chief Operating Officer | Feb 26 | Feb 27 | M | 8,322 | not reported | not reported | 245,003 | No | Form 4 |
| Jackson Blair CurtisEVP, Chief Operating Officer | Feb 26 | Feb 27 | F | 3,695 | $30.73 | $113,547 | 241,308 | No | Form 4 |
| Jackson Blair CurtisEVP, Chief Operating Officer | Feb 26 | Feb 27 | M · derivative | 8,322 | not reported | not reported | 16,645 | No | Form 4 |
| Nichols Christian ToddSVP, Chief Commercial Officer | Feb 26 | Feb 27 | M | 5,410 | not reported | not reported | 118,172 | No | Form 4 |
| Nichols Christian ToddSVP, Chief Commercial Officer | Feb 26 | Feb 27 | F | 2,403 | $30.73 | $73,844 | 115,769 | No | Form 4 |
| Nichols Christian ToddSVP, Chief Commercial Officer | Feb 26 | Feb 27 | M · derivative | 5,410 | not reported | not reported | 10,819 | No | Form 4 |
| Parisi Samuel JosephVP, Finance (Interim PAO) | Feb 26 | Feb 27 | M | 2,747 | not reported | not reported | 15,415 | No | Form 4 |
| Parisi Samuel JosephVP, Finance (Interim PAO) | Feb 26 | Feb 27 | F | 808 | $30.73 | $24,830 | 14,607 | No | Form 4 |
| Parisi Samuel JosephVP, Finance (Interim PAO) | Feb 26 | Feb 27 | M · derivative | 2,747 | not reported | not reported | 5,493 | No | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Feb 23 | Feb 25 | M | 7,689 | not reported | not reported | 239,291 | No | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Feb 23 | Feb 25 | F | 3,414 | $32.19 | $109,897 | 235,877 | No | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Feb 23 | Feb 25 | M · derivative | 7,689 | not reported | not reported | 7,690 | No | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 23 | Feb 25 | M | 7,689 | not reported | not reported | 92,986 | No | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 23 | Feb 25 | F | 3,414 | $32.19 | $109,897 | 89,572 | No | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 23 | Feb 25 | M · derivative | 7,689 | not reported | not reported | 7,690 | No | Form 4 |
| Jackson Blair CurtisEVP, Chief Operating Officer | Feb 23 | Feb 25 | M | 8,738 | not reported | not reported | 240,561 | No | Form 4 |
| Jackson Blair CurtisEVP, Chief Operating Officer | Feb 23 | Feb 25 | F | 3,880 | $32.19 | $124,897 | 236,681 | No | Form 4 |
| Jackson Blair CurtisEVP, Chief Operating Officer | Feb 23 | Feb 25 | M · derivative | 8,738 | not reported | not reported | 8,738 | No | Form 4 |
| Nichols Christian ToddSVP, Chief Commercial Officer | Feb 23 | Feb 25 | M | 6,407 | not reported | not reported | 115,607 | No | Form 4 |
| Nichols Christian ToddSVP, Chief Commercial Officer | Feb 23 | Feb 25 | F | 2,845 | $32.19 | $91,581 | 112,762 | No | Form 4 |
| Nichols Christian ToddSVP, Chief Commercial Officer | Feb 23 | Feb 25 | M · derivative | 6,407 | not reported | not reported | 6,408 | No | Form 4 |
| Parisi Samuel JosephVP, Finance (Interim PAO) | Feb 23 | Feb 25 | M | 2,283 | not reported | not reported | 13,340 | No | Form 4 |
| Parisi Samuel JosephVP, Finance (Interim PAO) | Feb 23 | Feb 25 | F | 672 | $32.19 | $21,632 | 12,668 | No | Form 4 |
| Parisi Samuel JosephVP, Finance (Interim PAO) | Feb 23 | Feb 25 | M · derivative | 2,283 | not reported | not reported | 2,284 | No | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Feb 19 | Feb 20 | M | 7,673 | not reported | not reported | 235,009 | No | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Feb 19 | Feb 20 | F | 3,407 | $32.00 | $109,024 | 231,602 | No | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Feb 19 | Feb 20 | M · derivative | 7,673 | not reported | not reported | 23,019 | No | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 19 | Feb 20 | M | 7,673 | not reported | not reported | 88,704 | No | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 19 | Feb 20 | F | 3,407 | $32.00 | $109,024 | 85,297 | No | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 19 | Feb 20 | M · derivative | 7,673 | not reported | not reported | 23,019 | No | Form 4 |
| Jackson Blair CurtisEVP, Chief Operating Officer | Feb 19 | Feb 20 | M | 9,300 | not reported | not reported | 235,953 | No | Form 4 |
| Jackson Blair CurtisEVP, Chief Operating Officer | Feb 19 | Feb 20 | F | 4,130 | $32.00 | $132,160 | 231,823 | No | Form 4 |
| Jackson Blair CurtisEVP, Chief Operating Officer | Feb 19 | Feb 20 | M · derivative | 9,300 | not reported | not reported | 27,903 | No | Form 4 |
| Nichols Christian ToddSVP, Chief Commercial Officer | Feb 19 | Feb 20 | M | 6,045 | not reported | not reported | 111,477 | No | Form 4 |
| Nichols Christian ToddSVP, Chief Commercial Officer | Feb 19 | Feb 20 | F | 2,277 | $32.00 | $72,864 | 109,200 | No | Form 4 |
| Nichols Christian ToddSVP, Chief Commercial Officer | Feb 19 | Feb 20 | M · derivative | 6,045 | not reported | not reported | 18,137 | No | Form 4 |
| Parisi Samuel JosephVP, Finance (Interim PAO) | Feb 19 | Feb 20 | M | 2,991 | not reported | not reported | 12,036 | No | Form 4 |
| Parisi Samuel JosephVP, Finance (Interim PAO) | Feb 19 | Feb 20 | F | 979 | $32.00 | $31,328 | 11,057 | No | Form 4 |
| Parisi Samuel JosephVP, Finance (Interim PAO) | Feb 19 | Feb 20 | M · derivative | 2,991 | not reported | not reported | 8,974 | No | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Feb 18 | Feb 20 | M | 6,355 | not reported | not reported | 229,462 | No | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Feb 18 | Feb 20 | F | 2,126 | $32.02 | $68,075 | 227,336 | No | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Feb 18 | Feb 20 | M · derivative | 6,355 | not reported | not reported | not reported | No | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 18 | Feb 20 | M | 8,897 | not reported | not reported | 84,535 | No | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 18 | Feb 20 | F | 3,504 | $32.02 | $112,198 | 81,031 | No | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 18 | Feb 20 | M · derivative | 8,897 | not reported | not reported | not reported | No | Form 4 |
| Jackson Blair CurtisEVP, Chief Operating Officer | Feb 18 | Feb 20 | M | 8,897 | not reported | not reported | 230,449 | No | Form 4 |
| Jackson Blair CurtisEVP, Chief Operating Officer | Feb 18 | Feb 20 | F | 3,796 | $32.02 | $121,548 | 226,653 | No | Form 4 |
| Jackson Blair CurtisEVP, Chief Operating Officer | Feb 18 | Feb 20 | M · derivative | 8,897 | not reported | not reported | not reported | No | Form 4 |
| Nichols Christian ToddSVP, Chief Commercial Officer | Feb 18 | Feb 20 | M | 6,355 | not reported | not reported | 107,301 | No | Form 4 |
| Nichols Christian ToddSVP, Chief Commercial Officer | Feb 18 | Feb 20 | F | 1,869 | $32.02 | $59,845 | 105,432 | No | Form 4 |
| Nichols Christian ToddSVP, Chief Commercial Officer | Feb 18 | Feb 20 | M · derivative | 6,355 | not reported | not reported | not reported | No | Form 4 |
| Parisi Samuel JosephVP, Finance (Interim PAO) | Feb 18 | Feb 20 | M | 2,034 | not reported | not reported | 9,751 | No | Form 4 |
| Parisi Samuel JosephVP, Finance (Interim PAO) | Feb 18 | Feb 20 | F | 706 | $32.02 | $22,606 | 9,045 | No | Form 4 |
| Parisi Samuel JosephVP, Finance (Interim PAO) | Feb 18 | Feb 20 | M · derivative | 2,034 | not reported | not reported | not reported | No | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Feb 5 | Feb 6 | A | 25,352 | not reported | not reported | 230,726 | No | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Feb 5 | Feb 6 | F | 7,619 | $33.55 | $255,617 | 223,107 | No | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 5 | Feb 6 | A | 25,352 | not reported | not reported | 83,092 | No | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 5 | Feb 6 | F | 7,454 | $33.55 | $250,082 | 75,638 | No | Form 4 |
| Jackson Blair CurtisEVP, Chief Operating Officer | Feb 5 | Feb 6 | A | 28,810 | not reported | not reported | 230,178 | No | Form 4 |
| Jackson Blair CurtisEVP, Chief Operating Officer | Feb 5 | Feb 6 | F | 8,626 | $33.55 | $289,402 | 221,552 | No | Form 4 |
| Nichols Christian ToddSVP, Chief Commercial Officer | Feb 5 | Feb 6 | A | 21,127 | not reported | not reported | 107,335 | No | Form 4 |
| Nichols Christian ToddSVP, Chief Commercial Officer | Feb 5 | Feb 6 | F | 6,389 | $33.55 | $214,351 | 100,946 | No | Form 4 |
| Pops Richard FDirector and CEO, Alkermes plc | Feb 5 | Feb 6 | A | 149,580 | not reported | not reported | 1,439,970 | No | Form 4 |
| Pops Richard FDirector and CEO, Alkermes plc | Feb 5 | Feb 6 | F | 62,230 | $33.55 | $2,087,817 | 1,377,740 | No | Form 4 |
| Cooke Shane | Feb 2 | Feb 2 | M | 61,200 | $31.64 | $1,936,368 | 164,944 | Yes | Form 4 |
| Cooke Shane | Feb 2 | Feb 2 | S | 29,087 | $34.34 | Sale −$998,848 | 135,857 | Yes | Form 4 |
| Cooke Shane | Feb 2 | Feb 2 | S | 32,113 | $34.78 | Sale −$1,116,890 | 103,744 | Yes | Form 4 |
| Cooke Shane | Feb 2 | Feb 2 | M · derivative | 61,200 | $31.64 | $1,936,368 | not reported | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 2 | Feb 2 | M | 5,000 | $19.34 | $96,700 | 66,740 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 2 | Feb 2 | S | 5,000 | $34.24 | Sale −$171,200 | 61,740 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 2 | Feb 2 | S | 4,000 | $33.54 | Sale −$134,160 | 57,740 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 2 | Feb 2 | M · derivative | 5,000 | $19.34 | $96,700 | 26,356 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Jan 8 | Jan 8 | M | 5,000 | $19.34 | $96,700 | 66,740 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Jan 8 | Jan 8 | S | 5,000 | $30.00 | Sale −$150,000 | 61,740 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Jan 8 | Jan 8 | M · derivative | 5,000 | $19.34 | $96,700 | 31,356 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Jan 2 | Jan 2 | S | 4,000 | $28.00 | Sale −$112,000 | 61,740 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Dec 3, 2025 | Dec 5, 2025 | M | 3,748 | $19.34 | $72,486 | 69,488 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Dec 3, 2025 | Dec 5, 2025 | S | 3,748 | $30.00 | Sale −$112,440 | 65,740 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Dec 3, 2025 | Dec 5, 2025 | M · derivative | 3,748 | $19.34 | $72,486 | 36,356 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Dec 1, 2025 | Dec 1, 2025 | S | 4,000 | $29.30 | Sale −$117,200 | 65,740 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Nov 3, 2025 | Nov 3, 2025 | M | 5,000 | $19.34 | $96,700 | 78,740 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Nov 3, 2025 | Nov 3, 2025 | S | 9,000 | $30.38 | Sale −$273,420 | 69,740 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Nov 3, 2025 | Nov 3, 2025 | M · derivative | 5,000 | $19.34 | $96,700 | 40,104 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Oct 15, 2025 | Oct 15, 2025 | M | 5,000 | $19.34 | $96,700 | 82,740 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Oct 15, 2025 | Oct 15, 2025 | S | 9,000 | $31.53 | Sale −$283,770 | 73,740 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Oct 15, 2025 | Oct 15, 2025 | M · derivative | 5,000 | $19.34 | $96,700 | 45,104 | Yes | Form 4 |
| Reed JoshuaSVP, Chief Financial Officer | Oct 8, 2025 | Oct 10, 2025 | A · derivative | 158,743 | $31.51 | $5,001,992 | 158,743 | No | Form 4 |
| Reed JoshuaSVP, Chief Financial Officer | Oct 8, 2025 | Oct 10, 2025 | A · derivative | 36,656 | $0.00 | $0 | 36,656 | No | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Aug 3, 2025 | Aug 4, 2025 | M | 2,014 | not reported | not reported | 206,269 | No | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Aug 3, 2025 | Aug 4, 2025 | F | 895 | $26.55 | $23,762 | 205,374 | No | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Aug 3, 2025 | Aug 4, 2025 | M · derivative | 2,014 | not reported | not reported | 2,015 | No | Form 4 |
| Nichols Christian ToddSVP, Chief Commercial Officer | Jun 10, 2025 | Jun 10, 2025 | S | 3,334 | $31.09 | Sale −$103,654 | 86,208 | Yes | Form 4 |
| Nichols Christian ToddSVP, Chief Commercial Officer | Jun 9, 2025 | Jun 10, 2025 | S | 3,333 | $31.95 | Sale −$106,489 | 89,542 | Yes | Form 4 |
| Wright Christopher I | Jun 8, 2025 | Jun 10, 2025 | M | 3,301 | not reported | not reported | 23,806 | No | Form 4 |
| Wright Christopher I | Jun 8, 2025 | Jun 10, 2025 | F | 793 | $31.71 | $25,146 | 23,013 | No | Form 4 |
| Wright Christopher I | Jun 8, 2025 | Jun 10, 2025 | M · derivative | 3,301 | not reported | not reported | not reported | No | Form 4 |
| Cooke Shane | May 31, 2025 | Jun 2, 2025 | M | 8,013 | not reported | not reported | 107,919 | No | Form 4 |
| Cooke Shane | May 31, 2025 | Jun 2, 2025 | F | 4,175 | $30.61 | $127,797 | 103,744 | No | Form 4 |
| Cooke Shane | May 31, 2025 | Jun 2, 2025 | M · derivative | 8,013 | not reported | not reported | not reported | No | Form 4 |
| Gaynor Richard | May 31, 2025 | Jun 2, 2025 | M | 8,013 | not reported | not reported | 33,008 | No | Form 4 |
| Gaynor Richard | May 31, 2025 | Jun 2, 2025 | F | 1,924 | $30.61 | $58,894 | 31,084 | No | Form 4 |
| Gaynor Richard | May 31, 2025 | Jun 2, 2025 | M · derivative | 8,013 | not reported | not reported | not reported | No | Form 4 |
| Laurencin Cato T | May 31, 2025 | Jun 2, 2025 | M | 8,013 | not reported | not reported | 31,026 | No | Form 4 |
| Laurencin Cato T | May 31, 2025 | Jun 2, 2025 | F | 1,924 | $30.61 | $58,894 | 29,102 | No | Form 4 |
| Laurencin Cato T | May 31, 2025 | Jun 2, 2025 | M · derivative | 8,013 | not reported | not reported | not reported | No | Form 4 |
| Lurker Nancy | May 31, 2025 | Jun 2, 2025 | M | 8,013 | not reported | not reported | 12,629 | No | Form 4 |
| Lurker Nancy | May 31, 2025 | Jun 2, 2025 | F | 1,924 | $30.61 | $58,894 | 10,705 | No | Form 4 |
| Lurker Nancy | May 31, 2025 | Jun 2, 2025 | M · derivative | 8,013 | not reported | not reported | not reported | No | Form 4 |
| Mckeon Brian P | May 31, 2025 | Jun 2, 2025 | M | 8,013 | not reported | not reported | 35,793 | No | Form 4 |
| Mckeon Brian P | May 31, 2025 | Jun 2, 2025 | F | 1,924 | $30.61 | $58,894 | 33,869 | No | Form 4 |
| Mckeon Brian P | May 31, 2025 | Jun 2, 2025 | M · derivative | 8,013 | not reported | not reported | not reported | No | Form 4 |
| snyderman nancy lynn MD | May 31, 2025 | Jun 2, 2025 | M | 8,013 | not reported | not reported | 12,652 | No | Form 4 |
| snyderman nancy lynn MD | May 31, 2025 | Jun 2, 2025 | F | 1,924 | $30.61 | $58,894 | 10,728 | No | Form 4 |
| snyderman nancy lynn MD | May 31, 2025 | Jun 2, 2025 | M · derivative | 8,013 | not reported | not reported | not reported | No | Form 4 |
| Wilson Frank Anders | May 31, 2025 | Jun 2, 2025 | M | 8,013 | not reported | not reported | 33,008 | No | Form 4 |
| Wilson Frank Anders | May 31, 2025 | Jun 2, 2025 | F | 1,924 | $30.61 | $58,894 | 31,084 | No | Form 4 |
| Wilson Frank Anders | May 31, 2025 | Jun 2, 2025 | M · derivative | 8,013 | not reported | not reported | not reported | No | Form 4 |
| Wright Christopher I | May 31, 2025 | Jun 2, 2025 | M | 8,013 | not reported | not reported | 22,429 | No | Form 4 |
| Wright Christopher I | May 31, 2025 | Jun 2, 2025 | F | 1,924 | $30.61 | $58,894 | 20,505 | No | Form 4 |
| Wright Christopher I | May 31, 2025 | Jun 2, 2025 | M · derivative | 8,013 | not reported | not reported | not reported | No | Form 4 |
| Cooke Shane | May 21, 2025 | May 23, 2025 | A · derivative | 13,474 | $30.53 | $411,361 | 13,474 | No | Form 4 |
| Cooke Shane | May 21, 2025 | May 23, 2025 | A · derivative | 6,142 | $0.00 | $0 | 6,142 | No | Form 4 |
| Gaynor Richard | May 21, 2025 | May 23, 2025 | A · derivative | 13,474 | $30.53 | $411,361 | 13,474 | No | Form 4 |
| Gaynor Richard | May 21, 2025 | May 23, 2025 | A · derivative | 6,142 | $0.00 | $0 | 6,142 | No | Form 4 |
| Laurencin Cato T | May 21, 2025 | May 23, 2025 | A · derivative | 13,474 | $30.53 | $411,361 | 13,474 | No | Form 4 |
| Laurencin Cato T | May 21, 2025 | May 23, 2025 | A · derivative | 6,142 | $0.00 | $0 | 6,142 | No | Form 4 |
| Lurker Nancy | May 21, 2025 | May 23, 2025 | A · derivative | 13,474 | $30.53 | $411,361 | 13,474 | No | Form 4 |
| Lurker Nancy | May 21, 2025 | May 23, 2025 | A · derivative | 6,142 | $0.00 | $0 | 6,142 | No | Form 4 |
| Mckeon Brian P | May 21, 2025 | May 23, 2025 | A · derivative | 13,474 | $30.53 | $411,361 | 13,474 | No | Form 4 |
| Mckeon Brian P | May 21, 2025 | May 23, 2025 | A · derivative | 6,142 | $0.00 | $0 | 6,142 | No | Form 4 |
| snyderman nancy lynn MD | May 21, 2025 | May 23, 2025 | A · derivative | 13,474 | $30.53 | $411,361 | 13,474 | No | Form 4 |
| snyderman nancy lynn MD | May 21, 2025 | May 23, 2025 | A · derivative | 6,142 | $0.00 | $0 | 6,142 | No | Form 4 |
| Wilson Frank Anders | May 21, 2025 | May 23, 2025 | A · derivative | 13,474 | $30.53 | $411,361 | 13,474 | No | Form 4 |
| Wilson Frank Anders | May 21, 2025 | May 23, 2025 | A · derivative | 6,142 | $0.00 | $0 | 6,142 | No | Form 4 |
| Wright Christopher I | May 21, 2025 | May 23, 2025 | A · derivative | 13,474 | $30.53 | $411,361 | 13,474 | No | Form 4 |
| Wright Christopher I | May 21, 2025 | May 23, 2025 | A · derivative | 6,142 | $0.00 | $0 | 6,142 | No | Form 4 |
| Lurker Nancy | Apr 11, 2025 | Apr 14, 2025 | M | 2,323 | not reported | not reported | 2,323 | No | Form 4 |
| Lurker Nancy | Apr 11, 2025 | Apr 14, 2025 | F | 558 | $27.00 | $15,066 | 1,765 | No | Form 4 |
| Lurker Nancy | Apr 11, 2025 | Apr 14, 2025 | M | 3,752 | not reported | not reported | 5,517 | No | Form 4 |
| Lurker Nancy | Apr 11, 2025 | Apr 14, 2025 | F | 901 | $27.00 | $24,327 | 4,616 | No | Form 4 |
| Lurker Nancy | Apr 11, 2025 | Apr 14, 2025 | M · derivative | 2,323 | not reported | not reported | not reported | No | Form 4 |
| Lurker Nancy | Apr 11, 2025 | Apr 14, 2025 | M · derivative | 3,752 | not reported | not reported | 7,503 | No | Form 4 |
| Parisi Samuel JosephVP, Finance (Interim PAO) | Feb 28, 2025 | Feb 28, 2025 | S | 1,938 | $34.00 | Sale −$65,892 | 7,717 | Yes | Form 4 |
| Brown Iain MichaelSVP, Chief Financial Officer | Feb 26, 2025 | Feb 28, 2025 | M | 5,617 | not reported | not reported | 150,690 | No | Form 4 |
| Brown Iain MichaelSVP, Chief Financial Officer | Feb 26, 2025 | Feb 28, 2025 | F | 2,494 | $34.80 | $86,791 | 148,196 | No | Form 4 |
| Brown Iain MichaelSVP, Chief Financial Officer | Feb 26, 2025 | Feb 28, 2025 | M · derivative | 5,617 | not reported | not reported | 16,854 | No | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Feb 26, 2025 | Feb 28, 2025 | M | 6,866 | not reported | not reported | 207,304 | No | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Feb 26, 2025 | Feb 28, 2025 | F | 3,049 | $34.80 | $106,105 | 204,255 | No | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Feb 26, 2025 | Feb 28, 2025 | M · derivative | 6,866 | not reported | not reported | 20,598 | No | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 26, 2025 | Feb 28, 2025 | M | 6,866 | not reported | not reported | 80,789 | No | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 26, 2025 | Feb 28, 2025 | F | 3,049 | $34.80 | $106,105 | 77,740 | No | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 26, 2025 | Feb 28, 2025 | M · derivative | 6,866 | not reported | not reported | 20,598 | No | Form 4 |
| Jackson Blair CurtisEVP, Chief Operating Officer | Feb 26, 2025 | Feb 28, 2025 | M | 8,322 | not reported | not reported | 205,063 | No | Form 4 |
| Jackson Blair CurtisEVP, Chief Operating Officer | Feb 26, 2025 | Feb 28, 2025 | F | 3,695 | $34.80 | $128,586 | 201,368 | No | Form 4 |
| Jackson Blair CurtisEVP, Chief Operating Officer | Feb 26, 2025 | Feb 28, 2025 | M · derivative | 8,322 | not reported | not reported | 24,967 | No | Form 4 |
| Nichols Christian ToddSVP, Chief Commercial Officer | Feb 26, 2025 | Feb 28, 2025 | M | 5,409 | not reported | not reported | 95,277 | No | Form 4 |
| Nichols Christian ToddSVP, Chief Commercial Officer | Feb 26, 2025 | Feb 28, 2025 | F | 2,402 | $34.80 | $83,590 | 92,875 | No | Form 4 |
| Nichols Christian ToddSVP, Chief Commercial Officer | Feb 26, 2025 | Feb 28, 2025 | M · derivative | 5,409 | not reported | not reported | 16,229 | No | Form 4 |
| Parisi Samuel JosephVP, Finance (Interim PAO) | Feb 26, 2025 | Feb 28, 2025 | M | 2,746 | not reported | not reported | 10,463 | Yes | Form 4 |
| Parisi Samuel JosephVP, Finance (Interim PAO) | Feb 26, 2025 | Feb 28, 2025 | F | 808 | $34.80 | $28,118 | 9,655 | Yes | Form 4 |
| Parisi Samuel JosephVP, Finance (Interim PAO) | Feb 26, 2025 | Feb 28, 2025 | M · derivative | 2,746 | not reported | not reported | 8,240 | Yes | Form 4 |
| Parisi Samuel JosephVP, Finance (Interim PAO) | Feb 25, 2025 | Feb 25, 2025 | S | 3,743 | $35.26 | Sale −$131,978 | 7,717 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 23, 2025 | Feb 25, 2025 | M | 7,689 | not reported | not reported | 77,337 | No | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 23, 2025 | Feb 25, 2025 | F | 3,414 | $35.32 | $120,582 | 73,923 | No | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 23, 2025 | Feb 25, 2025 | M · derivative | 7,689 | not reported | not reported | 15,379 | No | Form 4 |
| Nichols Christian ToddSVP, Chief Commercial Officer | Feb 23, 2025 | Feb 25, 2025 | M | 6,408 | not reported | not reported | 92,714 | No | Form 4 |
| Nichols Christian ToddSVP, Chief Commercial Officer | Feb 23, 2025 | Feb 25, 2025 | F | 2,846 | $35.32 | $100,521 | 89,868 | No | Form 4 |
| Nichols Christian ToddSVP, Chief Commercial Officer | Feb 23, 2025 | Feb 25, 2025 | M · derivative | 6,408 | not reported | not reported | 12,815 | No | Form 4 |
| Brown Iain MichaelSVP, Chief Financial Officer | Feb 23, 2025 | Feb 25, 2025 | M | 5,825 | not reported | not reported | 147,660 | No | Form 4 |
| Brown Iain MichaelSVP, Chief Financial Officer | Feb 23, 2025 | Feb 25, 2025 | F | 2,587 | $35.32 | $91,373 | 145,073 | No | Form 4 |
| Brown Iain MichaelSVP, Chief Financial Officer | Feb 23, 2025 | Feb 25, 2025 | M · derivative | 5,825 | not reported | not reported | 11,650 | No | Form 4 |
| Parisi Samuel JosephVP, Finance (Interim PAO) | Feb 23, 2025 | Feb 25, 2025 | M | 2,284 | not reported | not reported | 12,132 | Yes | Form 4 |
| Parisi Samuel JosephVP, Finance (Interim PAO) | Feb 23, 2025 | Feb 25, 2025 | F | 672 | $35.32 | $23,735 | 11,460 | Yes | Form 4 |
| Parisi Samuel JosephVP, Finance (Interim PAO) | Feb 23, 2025 | Feb 25, 2025 | M · derivative | 2,284 | not reported | not reported | 4,567 | Yes | Form 4 |
| Jackson Blair CurtisEVP, Chief Operating Officer | Feb 23, 2025 | Feb 25, 2025 | M | 8,738 | not reported | not reported | 200,621 | No | Form 4 |
| Jackson Blair CurtisEVP, Chief Operating Officer | Feb 23, 2025 | Feb 25, 2025 | F | 3,880 | $35.32 | $137,042 | 196,741 | No | Form 4 |
| Jackson Blair CurtisEVP, Chief Operating Officer | Feb 23, 2025 | Feb 25, 2025 | M · derivative | 8,738 | not reported | not reported | 17,476 | No | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Feb 23, 2025 | Feb 25, 2025 | M | 7,689 | not reported | not reported | 203,852 | No | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Feb 23, 2025 | Feb 25, 2025 | F | 3,414 | $35.32 | $120,582 | 200,438 | No | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Feb 23, 2025 | Feb 25, 2025 | M · derivative | 7,689 | not reported | not reported | 15,379 | No | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 22, 2025 | Feb 25, 2025 | M | 12,279 | not reported | not reported | 75,100 | No | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 22, 2025 | Feb 25, 2025 | F | 5,452 | $35.32 | $192,565 | 69,648 | No | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 22, 2025 | Feb 25, 2025 | M · derivative | 12,279 | not reported | not reported | not reported | No | Form 4 |
| Nichols Christian ToddSVP, Chief Commercial Officer | Feb 22, 2025 | Feb 25, 2025 | M | 7,109 | not reported | not reported | 89,463 | No | Form 4 |
| Nichols Christian ToddSVP, Chief Commercial Officer | Feb 22, 2025 | Feb 25, 2025 | F | 3,157 | $35.32 | $111,505 | 86,306 | No | Form 4 |
| Nichols Christian ToddSVP, Chief Commercial Officer | Feb 22, 2025 | Feb 25, 2025 | M · derivative | 7,109 | not reported | not reported | not reported | No | Form 4 |
| Brown Iain MichaelSVP, Chief Financial Officer | Feb 22, 2025 | Feb 25, 2025 | M | 7,109 | not reported | not reported | 144,989 | No | Form 4 |
| Brown Iain MichaelSVP, Chief Financial Officer | Feb 22, 2025 | Feb 25, 2025 | F | 3,154 | $35.32 | $111,399 | 141,835 | No | Form 4 |
| Brown Iain MichaelSVP, Chief Financial Officer | Feb 22, 2025 | Feb 25, 2025 | M · derivative | 7,109 | not reported | not reported | not reported | No | Form 4 |
| Parisi Samuel JosephVP, Finance (Interim PAO) | Feb 22, 2025 | Feb 25, 2025 | M | 3,114 | not reported | not reported | 10,831 | Yes | Form 4 |
| Parisi Samuel JosephVP, Finance (Interim PAO) | Feb 22, 2025 | Feb 25, 2025 | F | 983 | $35.32 | $34,720 | 9,848 | Yes | Form 4 |
| Parisi Samuel JosephVP, Finance (Interim PAO) | Feb 22, 2025 | Feb 25, 2025 | M · derivative | 3,114 | not reported | not reported | not reported | Yes | Form 4 |
| Jackson Blair CurtisEVP, Chief Operating Officer | Feb 22, 2025 | Feb 25, 2025 | M | 9,694 | not reported | not reported | 196,188 | No | Form 4 |
| Jackson Blair CurtisEVP, Chief Operating Officer | Feb 22, 2025 | Feb 25, 2025 | F | 4,305 | $35.32 | $152,053 | 191,883 | No | Form 4 |
| Jackson Blair CurtisEVP, Chief Operating Officer | Feb 22, 2025 | Feb 25, 2025 | M · derivative | 9,694 | not reported | not reported | not reported | No | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Feb 22, 2025 | Feb 25, 2025 | M | 7,432 | not reported | not reported | 199,463 | No | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Feb 22, 2025 | Feb 25, 2025 | F | 3,300 | $35.32 | $116,556 | 196,163 | No | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Feb 22, 2025 | Feb 25, 2025 | M · derivative | 7,432 | not reported | not reported | not reported | No | Form 4 |
| Parisi Samuel JosephVP, Finance (Interim PAO) | Feb 20, 2025 | Feb 20, 2025 | S | 1,327 | $35.69 | Sale −$47,361 | 7,717 | Yes | Form 4 |
| Pops Richard FDirector and CEO, Alkermes plc | Feb 19, 2025 | Feb 20, 2025 | A · derivative | 293,921 | $35.84 | $10,534,129 | 293,921 | No | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 19, 2025 | Feb 20, 2025 | A · derivative | 63,991 | $35.84 | $2,293,437 | 63,991 | No | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 19, 2025 | Feb 20, 2025 | A · derivative | 30,692 | $0.00 | $0 | 30,692 | No | Form 4 |
| Jackson Blair CurtisEVP, Chief Operating Officer | Feb 19, 2025 | Feb 20, 2025 | A · derivative | 77,565 | $35.84 | $2,779,930 | 77,565 | No | Form 4 |
| Jackson Blair CurtisEVP, Chief Operating Officer | Feb 19, 2025 | Feb 20, 2025 | A · derivative | 37,203 | $0.00 | $0 | 37,203 | No | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Feb 19, 2025 | Feb 20, 2025 | A · derivative | 63,991 | $35.84 | $2,293,437 | 63,991 | No | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Feb 19, 2025 | Feb 20, 2025 | A · derivative | 30,692 | $0.00 | $0 | 30,692 | No | Form 4 |
| Nichols Christian ToddSVP, Chief Commercial Officer | Feb 19, 2025 | Feb 20, 2025 | A · derivative | 50,417 | $35.84 | $1,806,945 | 50,417 | No | Form 4 |
| Nichols Christian ToddSVP, Chief Commercial Officer | Feb 19, 2025 | Feb 20, 2025 | A · derivative | 24,182 | $0.00 | $0 | 24,182 | No | Form 4 |
| Parisi Samuel JosephVP, Finance (Interim PAO) | Feb 19, 2025 | Feb 20, 2025 | A · derivative | 12,287 | $35.84 | $440,366 | 12,287 | Yes | Form 4 |
| Parisi Samuel JosephVP, Finance (Interim PAO) | Feb 19, 2025 | Feb 20, 2025 | A · derivative | 11,965 | $0.00 | $0 | 11,965 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 18, 2025 | Feb 20, 2025 | M | 8,896 | not reported | not reported | 66,771 | No | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 18, 2025 | Feb 20, 2025 | F | 3,950 | $35.90 | $141,805 | 62,821 | No | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 18, 2025 | Feb 20, 2025 | M · derivative | 8,896 | not reported | not reported | 8,897 | No | Form 4 |
| Jackson Blair CurtisEVP, Chief Operating Officer | Feb 18, 2025 | Feb 20, 2025 | M | 8,896 | not reported | not reported | 190,444 | No | Form 4 |
| Jackson Blair CurtisEVP, Chief Operating Officer | Feb 18, 2025 | Feb 20, 2025 | F | 3,950 | $35.90 | $141,805 | 186,494 | No | Form 4 |
| Jackson Blair CurtisEVP, Chief Operating Officer | Feb 18, 2025 | Feb 20, 2025 | M · derivative | 8,896 | not reported | not reported | 8,897 | No | Form 4 |
| Brown Iain MichaelSVP, Chief Financial Officer | Feb 18, 2025 | Feb 20, 2025 | M | 6,354 | not reported | not reported | 139,749 | No | Form 4 |
| Brown Iain MichaelSVP, Chief Financial Officer | Feb 18, 2025 | Feb 20, 2025 | F | 1,869 | $35.90 | $67,097 | 137,880 | No | Form 4 |
| Brown Iain MichaelSVP, Chief Financial Officer | Feb 18, 2025 | Feb 20, 2025 | M · derivative | 6,354 | not reported | not reported | 6,355 | No | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Feb 18, 2025 | Feb 20, 2025 | M | 6,354 | not reported | not reported | 194,853 | No | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Feb 18, 2025 | Feb 20, 2025 | F | 2,822 | $35.90 | $101,310 | 192,031 | No | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Feb 18, 2025 | Feb 20, 2025 | M · derivative | 6,354 | not reported | not reported | 6,355 | No | Form 4 |
| Nichols Christian ToddSVP, Chief Commercial Officer | Feb 18, 2025 | Feb 20, 2025 | M | 6,354 | not reported | not reported | 84,223 | No | Form 4 |
| Nichols Christian ToddSVP, Chief Commercial Officer | Feb 18, 2025 | Feb 20, 2025 | F | 1,869 | $35.90 | $67,097 | 82,354 | No | Form 4 |
| Nichols Christian ToddSVP, Chief Commercial Officer | Feb 18, 2025 | Feb 20, 2025 | M · derivative | 6,354 | not reported | not reported | 6,355 | No | Form 4 |
| Parisi Samuel JosephVP, Finance (Interim PAO) | Feb 18, 2025 | Feb 20, 2025 | M | 2,033 | not reported | not reported | 9,750 | Yes | Form 4 |
| Parisi Samuel JosephVP, Finance (Interim PAO) | Feb 18, 2025 | Feb 20, 2025 | F | 706 | $35.90 | $25,345 | 9,044 | Yes | Form 4 |
| Parisi Samuel JosephVP, Finance (Interim PAO) | Feb 18, 2025 | Feb 20, 2025 | M · derivative | 2,033 | not reported | not reported | 2,034 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 13, 2025 | Feb 14, 2025 | M | 108,833 | $31.93 | $3,475,038 | 166,708 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 13, 2025 | Feb 14, 2025 | M | 35,586 | $24.59 | $875,060 | 202,294 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 13, 2025 | Feb 14, 2025 | S | 35,586 | $34.02 | Sale −$1,210,636 | 166,708 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 13, 2025 | Feb 14, 2025 | S | 108,833 | $36.02 | Sale −$3,920,165 | 57,875 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 13, 2025 | Feb 14, 2025 | M · derivative | 108,833 | $31.93 | $3,475,038 | not reported | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 13, 2025 | Feb 14, 2025 | M · derivative | 35,586 | $24.59 | $875,060 | 71,172 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 12, 2025 | Feb 14, 2025 | M | 87,566 | $20.03 | $1,753,947 | 151,166 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 12, 2025 | Feb 14, 2025 | M | 111,630 | $19.34 | $2,158,924 | 262,796 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 12, 2025 | Feb 14, 2025 | S | 171,813 | $32.69 | Sale −$5,616,567 | 90,983 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 12, 2025 | Feb 14, 2025 | S | 33,108 | $33.27 | Sale −$1,101,503 | 57,875 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 12, 2025 | Feb 14, 2025 | M · derivative | 87,566 | $20.03 | $1,753,947 | not reported | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 12, 2025 | Feb 14, 2025 | M · derivative | 111,630 | $19.34 | $2,158,924 | 50,104 | Yes | Form 4 |
| Brown Iain MichaelSVP, Chief Financial Officer | Feb 6, 2025 | Feb 7, 2025 | A | 24,565 | not reported | not reported | 140,909 | No | Form 4 |
| Brown Iain MichaelSVP, Chief Financial Officer | Feb 6, 2025 | Feb 7, 2025 | F | 7,514 | $31.39 | $235,864 | 133,395 | No | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Feb 6, 2025 | Feb 7, 2025 | A | 32,350 | not reported | not reported | 198,251 | No | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Feb 6, 2025 | Feb 7, 2025 | F | 9,752 | $31.39 | $306,115 | 188,499 | No | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 6, 2025 | Feb 7, 2025 | A | 34,393 | not reported | not reported | 78,683 | No | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Feb 6, 2025 | Feb 7, 2025 | F | 15,083 | $31.39 | $473,455 | 63,600 | No | Form 4 |
| Jackson Blair CurtisEVP, Chief Operating Officer | Feb 6, 2025 | Feb 7, 2025 | A | 34,393 | not reported | not reported | 192,195 | No | Form 4 |
| Jackson Blair CurtisEVP, Chief Operating Officer | Feb 6, 2025 | Feb 7, 2025 | F | 10,647 | $31.39 | $334,209 | 181,548 | No | Form 4 |
| Nichols Christian ToddSVP, Chief Commercial Officer | Feb 6, 2025 | Feb 7, 2025 | A | 24,565 | not reported | not reported | 85,268 | No | Form 4 |
| Nichols Christian ToddSVP, Chief Commercial Officer | Feb 6, 2025 | Feb 7, 2025 | F | 7,399 | $31.39 | $232,255 | 77,869 | No | Form 4 |
| Pops Richard FDirector and CEO, Alkermes plc | Feb 6, 2025 | Feb 7, 2025 | A | 190,640 | not reported | not reported | 1,370,315 | No | Form 4 |
| Pops Richard FDirector and CEO, Alkermes plc | Feb 6, 2025 | Feb 7, 2025 | F | 79,925 | $31.39 | $2,508,846 | 1,290,390 | No | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Jan 30, 2025 | Jan 31, 2025 | M | 29,156 | $20.03 | $583,995 | 76,732 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Jan 30, 2025 | Jan 31, 2025 | M | 26,589 | $19.34 | $514,231 | 103,321 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Jan 30, 2025 | Jan 31, 2025 | M | 23,542 | $24.59 | $578,898 | 126,863 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Jan 30, 2025 | Jan 31, 2025 | M | 18,345 | $26.82 | $492,013 | 145,208 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Jan 30, 2025 | Jan 31, 2025 | S | 100,918 | $32.05 | Sale −$3,234,422 | 44,290 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Jan 30, 2025 | Jan 31, 2025 | M · derivative | 29,156 | $20.03 | $583,995 | 87,566 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Jan 30, 2025 | Jan 31, 2025 | M · derivative | 26,589 | $19.34 | $514,231 | 161,734 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Jan 30, 2025 | Jan 31, 2025 | M · derivative | 23,542 | $24.59 | $578,898 | 106,758 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Jan 30, 2025 | Jan 31, 2025 | M · derivative | 18,345 | $26.82 | $492,013 | 92,271 | Yes | Form 4 |
| Laurencin Cato T | Dec 9, 2024 | Dec 9, 2024 | M | 2,691 | $22.52 | $60,601 | 25,704 | Yes | Form 4 |
| Laurencin Cato T | Dec 9, 2024 | Dec 9, 2024 | S | 2,691 | $31.85 | Sale −$85,708 | 23,013 | Yes | Form 4 |
| Laurencin Cato T | Dec 9, 2024 | Dec 9, 2024 | M · derivative | 2,691 | $22.52 | $60,601 | 16,142 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Dec 9, 2024 | Dec 9, 2024 | M | 12,452 | $20.03 | $249,414 | 72,182 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Dec 9, 2024 | Dec 9, 2024 | M | 12,090 | $19.34 | $233,821 | 84,272 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Dec 9, 2024 | Dec 9, 2024 | M | 12,044 | $24.59 | $296,162 | 96,316 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Dec 9, 2024 | Dec 9, 2024 | M | 12,411 | $26.82 | $332,863 | 108,727 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Dec 9, 2024 | Dec 9, 2024 | S | 61,151 | $32.07 | Sale −$1,961,113 | 47,576 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Dec 9, 2024 | Dec 9, 2024 | M · derivative | 12,452 | $20.03 | $249,414 | 116,722 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Dec 9, 2024 | Dec 9, 2024 | M · derivative | 12,090 | $19.34 | $233,821 | 188,323 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Dec 9, 2024 | Dec 9, 2024 | M · derivative | 12,044 | $24.59 | $296,162 | 130,300 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Dec 9, 2024 | Dec 9, 2024 | M · derivative | 12,411 | $26.82 | $332,863 | 110,616 | Yes | Form 4 |
| Laurencin Cato T | Dec 8, 2024 | Dec 9, 2024 | M | 4,163 | not reported | not reported | 23,971 | Yes | Form 4 |
| Laurencin Cato T | Dec 8, 2024 | Dec 9, 2024 | F | 958 | $31.46 | $30,139 | 23,013 | Yes | Form 4 |
| Laurencin Cato T | Dec 8, 2024 | Dec 9, 2024 | M · derivative | 4,163 | not reported | not reported | not reported | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Dec 5, 2024 | Dec 5, 2024 | S | 9,221 | $31.50 | Sale −$290,462 | 59,730 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Dec 4, 2024 | Dec 4, 2024 | S | 14,349 | $30.77 | Sale −$441,519 | 68,951 | Yes | Form 4 |
| Nichols Christian ToddSVP, Chief Commercial Officer | Nov 27, 2024 | Nov 27, 2024 | S | 5,208 | $29.15 | Sale −$151,813 | 60,703 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Nov 11, 2024 | Nov 12, 2024 | M | 43,058 | $20.03 | $862,452 | 142,296 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Nov 11, 2024 | Nov 12, 2024 | S | 58,996 | $30.08 | Sale −$1,774,600 | 83,300 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Nov 11, 2024 | Nov 12, 2024 | M · derivative | 43,058 | $20.03 | $862,452 | 129,174 | Yes | Form 4 |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Nov 6, 2024 | Nov 6, 2024 | S | 10,471 | $29.53 | Sale −$309,209 | 99,238 | Yes | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Aug 3, 2024 | Aug 5, 2024 | M | 2,014 | not reported | not reported | 166,796 | No | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Aug 3, 2024 | Aug 5, 2024 | F | 895 | $27.72 | $24,809 | 165,901 | No | Form 4 |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Aug 3, 2024 | Aug 5, 2024 | M · derivative | 2,014 | not reported | not reported | 4,029 | No | Form 4 |
| Alva Emily Peterson | Jun 29, 2024 | Jul 1, 2024 | M | 6,104 | not reported | not reported | 28,767 | No | Form 4 |
| Alva Emily Peterson | Jun 29, 2024 | Jul 1, 2024 | F | 1,465 | $24.10 | $35,307 | 27,302 | No | Form 4 |
| Alva Emily Peterson | Jun 29, 2024 | Jul 1, 2024 | M · derivative | 6,104 | not reported | not reported | not reported | No | Form 4 |
| Cooke Shane | Jun 29, 2024 | Jul 1, 2024 | M | 6,104 | not reported | not reported | 103,081 | No | Form 4 |
| Cooke Shane | Jun 29, 2024 | Jul 1, 2024 | F | 3,175 | $24.10 | $76,518 | 99,906 | No | Form 4 |
| Cooke Shane | Jun 29, 2024 | Jul 1, 2024 | M · derivative | 6,104 | not reported | not reported | not reported | No | Form 4 |
| Daglio David Angelo Jr. | Jun 29, 2024 | Jul 1, 2024 | M | 6,104 | not reported | not reported | 29,245 | No | Form 4 |
| Daglio David Angelo Jr. | Jun 29, 2024 | Jul 1, 2024 | F | 1,465 | $24.10 | $35,307 | 27,780 | No | Form 4 |
| Daglio David Angelo Jr. | Jun 29, 2024 | Jul 1, 2024 | M · derivative | 6,104 | not reported | not reported | not reported | No | Form 4 |
| Gaynor Richard | Jun 29, 2024 | Jul 1, 2024 | M | 6,104 | not reported | not reported | 26,460 | No | Form 4 |
| Gaynor Richard | Jun 29, 2024 | Jul 1, 2024 | F | 1,465 | $24.10 | $35,307 | 24,995 | No | Form 4 |
| Gaynor Richard | Jun 29, 2024 | Jul 1, 2024 | M · derivative | 6,104 | not reported | not reported | not reported | No | Form 4 |
| Laurencin Cato T | Jun 29, 2024 | Jul 1, 2024 | M | 6,104 | not reported | not reported | 21,273 | No | Form 4 |
| Laurencin Cato T | Jun 29, 2024 | Jul 1, 2024 | F | 1,465 | $24.10 | $35,307 | 19,808 | No | Form 4 |
| Laurencin Cato T | Jun 29, 2024 | Jul 1, 2024 | M · derivative | 6,104 | not reported | not reported | not reported | No | Form 4 |
| Mckeon Brian P | Jun 29, 2024 | Jul 1, 2024 | M | 6,104 | not reported | not reported | 29,245 | No | Form 4 |
| Mckeon Brian P | Jun 29, 2024 | Jul 1, 2024 | F | 1,465 | $24.10 | $35,307 | 27,780 | No | Form 4 |
| Mckeon Brian P | Jun 29, 2024 | Jul 1, 2024 | M · derivative | 6,104 | not reported | not reported | not reported | No | Form 4 |
| snyderman nancy lynn MD | Jun 29, 2024 | Jul 1, 2024 | M | 6,104 | not reported | not reported | 6,104 | No | Form 4 |
| snyderman nancy lynn MD | Jun 29, 2024 | Jul 1, 2024 | F | 1,465 | $24.10 | $35,307 | 4,639 | No | Form 4 |
| snyderman nancy lynn MD | Jun 29, 2024 | Jul 1, 2024 | M · derivative | 6,104 | not reported | not reported | not reported | No | Form 4 |
| Wilson Frank Anders | Jun 29, 2024 | Jul 1, 2024 | M | 6,104 | not reported | not reported | 26,460 | No | Form 4 |
| Wilson Frank Anders | Jun 29, 2024 | Jul 1, 2024 | F | 1,465 | $24.10 | $35,307 | 24,995 | No | Form 4 |
| Wilson Frank Anders | Jun 29, 2024 | Jul 1, 2024 | M · derivative | 6,104 | not reported | not reported | not reported | No | Form 4 |
| Wright Christopher I | Jun 29, 2024 | Jul 1, 2024 | M | 6,104 | not reported | not reported | 15,881 | No | Form 4 |
| Wright Christopher I | Jun 29, 2024 | Jul 1, 2024 | F | 1,465 | $24.10 | $35,307 | 14,416 | No | Form 4 |
| Wright Christopher I | Jun 29, 2024 | Jul 1, 2024 | M · derivative | 6,104 | not reported | not reported | not reported | No | Form 4 |
| Alva Emily Peterson | Jun 9, 2024 | Jun 10, 2024 | M | 3,871 | not reported | not reported | 23,593 | No | Form 4 |
| Alva Emily Peterson | Jun 9, 2024 | Jun 10, 2024 | F | 930 | $23.91 | $22,236 | 22,663 | No | Form 4 |
| Alva Emily Peterson | Jun 9, 2024 | Jun 10, 2024 | M · derivative | 3,871 | not reported | not reported | not reported | No | Form 4 |
| Wright Christopher I | Jun 8, 2024 | Jun 10, 2024 | M | 3,301 | not reported | not reported | 10,570 | No | Form 4 |
| Wright Christopher I | Jun 8, 2024 | Jun 10, 2024 | F | 793 | $23.91 | $18,961 | 9,777 | No | Form 4 |
| Wright Christopher I | Jun 8, 2024 | Jun 10, 2024 | M · derivative | 3,301 | not reported | not reported | 3,301 | No | Form 4 |
| Alva Emily Peterson | May 31, 2024 | Jun 4, 2024 | A · derivative | 8,013 | $0.00 | $0 | 8,013 | No | Form 4 |
| Alva Emily Peterson | May 31, 2024 | Jun 4, 2024 | A · derivative | 17,492 | $23.40 | $409,313 | 17,492 | No | Form 4 |
| Cooke Shane | May 31, 2024 | Jun 4, 2024 | A · derivative | 8,013 | $0.00 | $0 | 8,013 | No | Form 4 |
| Cooke Shane | May 31, 2024 | Jun 4, 2024 | A · derivative | 17,492 | $23.40 | $409,313 | 17,492 | No | Form 4 |
| Daglio David Angelo Jr. | May 31, 2024 | Jun 4, 2024 | A · derivative | 8,013 | $0.00 | $0 | 8,013 | No | Form 4 |
| Daglio David Angelo Jr. | May 31, 2024 | Jun 4, 2024 | A · derivative | 17,492 | $23.40 | $409,313 | 17,492 | No | Form 4 |
| Gaynor Richard | May 31, 2024 | Jun 4, 2024 | A · derivative | 8,013 | $0.00 | $0 | 8,013 | No | Form 4 |
| Gaynor Richard | May 31, 2024 | Jun 4, 2024 | A · derivative | 17,492 | $23.40 | $409,313 | 17,492 | No | Form 4 |
| Laurencin Cato T | May 31, 2024 | Jun 4, 2024 | A · derivative | 8,013 | $0.00 | $0 | 8,013 | No | Form 4 |
| Laurencin Cato T | May 31, 2024 | Jun 4, 2024 | A · derivative | 17,492 | $23.40 | $409,313 | 17,492 | No | Form 4 |
| Lurker Nancy | May 31, 2024 | Jun 4, 2024 | A · derivative | 8,013 | $0.00 | $0 | 8,013 | No | Form 4 |
| Lurker Nancy | May 31, 2024 | Jun 4, 2024 | A · derivative | 17,492 | $23.40 | $409,313 | 17,492 | No | Form 4 |
| Mckeon Brian P | May 31, 2024 | Jun 4, 2024 | A · derivative | 8,013 | $0.00 | $0 | 8,013 | No | Form 4 |
| Mckeon Brian P | May 31, 2024 | Jun 4, 2024 | A · derivative | 17,492 | $23.40 | $409,313 | 17,492 | No | Form 4 |
| snyderman nancy lynn MD | May 31, 2024 | Jun 4, 2024 | A · derivative | 8,013 | $0.00 | $0 | 8,013 | No | Form 4 |
| snyderman nancy lynn MD | May 31, 2024 | Jun 4, 2024 | A · derivative | 17,492 | $23.40 | $409,313 | 17,492 | No | Form 4 |
| Wilson Frank Anders | May 31, 2024 | Jun 4, 2024 | A · derivative | 8,013 | $0.00 | $0 | 8,013 | No | Form 4 |
| Wilson Frank Anders | May 31, 2024 | Jun 4, 2024 | A · derivative | 17,492 | $23.40 | $409,313 | 17,492 | No | Form 4 |
| Wright Christopher I | May 31, 2024 | Jun 4, 2024 | A · derivative | 8,013 | $0.00 | $0 | 8,013 | No | Form 4 |
| Wright Christopher I | May 31, 2024 | Jun 4, 2024 | A · derivative | 17,492 | $23.40 | $409,313 | 17,492 | No | Form 4 |
| Alva Emily Peterson | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 22 | $24.22 | $533 | 1,137 | No | Form 4 |
| Alva Emily Peterson | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 455 | $24.22 | $11,020 | 23,214 | No | Form 4 |
| Alva Emily Peterson | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 75 | not reported | not reported | 3,871 | No | Form 4 |
| Alva Emily Peterson | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 313 | $24.24 | $7,587 | 15,990 | No | Form 4 |
| Alva Emily Peterson | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 231 | $30.86 | $7,129 | 11,785 | No | Form 4 |
| Alva Emily Peterson | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 254 | $30.72 | $7,803 | 12,986 | No | Form 4 |
| Alva Emily Peterson | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 119 | not reported | not reported | 6,104 | No | Form 4 |
| Cooke Shane | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 1,102 | $69.83 | $76,953 | 56,227 | No | Form 4 |
| Cooke Shane | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 1,200 | $31.64 | $37,968 | 61,200 | No | Form 4 |
| Cooke Shane | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 425 | $53.50 | $22,738 | 21,675 | No | Form 4 |
| Cooke Shane | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 520 | $44.75 | $23,270 | 26,520 | No | Form 4 |
| Cooke Shane | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 350 | $44.75 | $15,663 | 17,850 | No | Form 4 |
| Cooke Shane | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 448 | $24.55 | $10,998 | 22,848 | No | Form 4 |
| Cooke Shane | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 256 | $16.52 | $4,229 | 13,079 | No | Form 4 |
| Cooke Shane | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 230 | $18.45 | $4,244 | 11,739 | No | Form 4 |
| Cooke Shane | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 313 | $24.24 | $7,587 | 15,990 | No | Form 4 |
| Cooke Shane | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 231 | $30.86 | $7,129 | 11,785 | No | Form 4 |
| Cooke Shane | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 254 | $30.72 | $7,803 | 12,986 | No | Form 4 |
| Cooke Shane | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 119 | not reported | not reported | 6,104 | No | Form 4 |
| Gaynor Richard | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 1,236 | $20.81 | $25,721 | 63,036 | No | Form 4 |
| Gaynor Richard | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 224 | $20.81 | $4,661 | 11,424 | No | Form 4 |
| Gaynor Richard | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 256 | $16.52 | $4,229 | 13,079 | No | Form 4 |
| Gaynor Richard | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 230 | $18.45 | $4,244 | 11,739 | No | Form 4 |
| Gaynor Richard | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 313 | $24.24 | $7,587 | 15,990 | No | Form 4 |
| Gaynor Richard | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 231 | $30.86 | $7,129 | 11,785 | No | Form 4 |
| Gaynor Richard | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 254 | $30.72 | $7,803 | 12,986 | No | Form 4 |
| Gaynor Richard | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 119 | not reported | not reported | 6,104 | No | Form 4 |
| snyderman nancy lynn MD | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 548 | $46.72 | $25,603 | 27,948 | No | Form 4 |
| snyderman nancy lynn MD | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 324 | $46.72 | $15,137 | 16,524 | No | Form 4 |
| snyderman nancy lynn MD | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 284 | $57.11 | $16,219 | 14,484 | No | Form 4 |
| snyderman nancy lynn MD | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 350 | $44.75 | $15,663 | 17,850 | No | Form 4 |
| snyderman nancy lynn MD | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 448 | $24.55 | $10,998 | 22,848 | No | Form 4 |
| snyderman nancy lynn MD | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 256 | $16.52 | $4,229 | 13,079 | No | Form 4 |
| snyderman nancy lynn MD | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 230 | $18.45 | $4,244 | 11,739 | No | Form 4 |
| snyderman nancy lynn MD | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 313 | $24.24 | $7,587 | 15,990 | No | Form 4 |
| snyderman nancy lynn MD | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 231 | $30.86 | $7,129 | 11,785 | No | Form 4 |
| snyderman nancy lynn MD | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 254 | $30.72 | $7,803 | 12,986 | No | Form 4 |
| snyderman nancy lynn MD | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 119 | not reported | not reported | 6,104 | No | Form 4 |
| Wilson Frank Anders | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 1,236 | $20.81 | $25,721 | 63,036 | No | Form 4 |
| Wilson Frank Anders | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 224 | $20.81 | $4,661 | 11,424 | No | Form 4 |
| Wilson Frank Anders | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 256 | $16.52 | $4,229 | 13,079 | No | Form 4 |
| Wilson Frank Anders | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 230 | $18.45 | $4,244 | 11,739 | No | Form 4 |
| Wilson Frank Anders | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 313 | $24.24 | $7,587 | 15,990 | No | Form 4 |
| Wilson Frank Anders | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 231 | $30.86 | $7,129 | 11,785 | No | Form 4 |
| Wilson Frank Anders | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 254 | $30.72 | $7,803 | 12,986 | No | Form 4 |
| Wilson Frank Anders | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 119 | not reported | not reported | 6,104 | No | Form 4 |
| Wright Christopher I | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 14 | $28.40 | $398 | 728 | No | Form 4 |
| Wright Christopher I | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 355 | $28.40 | $10,082 | 18,128 | No | Form 4 |
| Wright Christopher I | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 129 | not reported | not reported | 6,602 | No | Form 4 |
| Wright Christopher I | Nov 17, 2023 | Jun 4, 2024 | J · derivative | 231 | $30.86 | $7,129 | 11,785 | No | Form 4 |